How many studies have been conducted on Porfiromycin?

BiohacksAI has indexed 101 PubMed studies on Porfiromycin, including 3 randomized controlled trials (RCTs). 22% of studies involve human subjects.

What are the main research areas for Porfiromycin?

The primary research domains for Porfiromycin are 🔬 Oncology, 🫁 Liver & Detox, 🧠 Focus & Attention. This is based on analysis of 101 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Porfiromycin

the mitomycin group, obtained from MITOMYCIN and also from Streptomyces ardus and other species. It is proposed as an antineoplastic agent, with some antibiotic properties.

101+ PubMed studies analyzed · 3 RCTs · Evidence Score: 38.9

Research Domains

Porfiromycin has been studied across 14 research domains including 🔬 Oncology, 🫁 Liver & Detox, 🧠 Focus & Attention, 🔬 Inflammation, ⚡ Energy & Fatigue. The primary research focus is 🔬 Oncology with 57% of studies addressing this area.

Loading evidence profile...

This evidence profile for Porfiromycin is generated deterministically from 101 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.